Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

The epidermal growth factor receptor (EGFR) pathway is a well-studied oncogenic pathway in human non-small cell lung cancer (NSCLC). A subset of advanced NSCLC patients (15–55%) have EGFR-driven mutations and benefit from treatment with EGFR-tyrosine kinase inhibitors (TKIs). Immune checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Ping-Chih, Jablons, David M., Yang, Cheng-Ta, You, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695603/
https://www.ncbi.nlm.nih.gov/pubmed/31387256
http://dx.doi.org/10.3390/ijms20153821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695603/
https://www.ncbi.nlm.nih.gov/pubmed/31387256
http://dx.doi.org/10.3390/ijms20153821

Ejemplares similares